# Evaluation of the Efficacy and Safety of Palmitoleic Acid Oil Composition in Preventing Pressure Injuries

> **NCT07547254** · NA · ENROLLING_BY_INVITATION · sponsor: **Ruijin Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Pressure Ulcer Prevention

## Interventions

- **COMBINATION_PRODUCT:** Topical POA Oil Composition Application for Pressure Injury Prevention

## Key facts

- **NCT ID:** NCT07547254
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07547254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07547254, "Evaluation of the Efficacy and Safety of Palmitoleic Acid Oil Composition in Preventing Pressure Injuries". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07547254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*